Pharmaron Beijing Co Ltd (300759) — Cash Flow-to-Debt Ratio
Pharmaron Beijing Co Ltd (300759) has a Cash Flow-to-Debt Ratio of 0.10x as of September 2025, meaning its operating cash flow of CN¥1.04 Billion could theoretically repay 0% of its total liabilities (CN¥10.62 Billion) in one year. Check Pharmaron Beijing Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pharmaron Beijing Co Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Pharmaron Beijing Co Ltd across 11 annual periods. Also explore balance sheet size of Pharmaron Beijing Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Pharmaron Beijing Co Ltd (2014–2024)
Year-by-year debt coverage analysis for Pharmaron Beijing Co Ltd. For market capitalisation and broader financial context, see market value of Pharmaron Beijing Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.27x | CN¥2.58 Billion | CN¥9.70 Billion | ▲ +27.7% |
| 2023 | 0.21x | CN¥2.75 Billion | CN¥13.24 Billion | ▼ -6.3% |
| 2022 | 0.22x | CN¥2.14 Billion | CN¥9.65 Billion | ▼ -12.7% |
| 2021 | 0.25x | CN¥2.06 Billion | CN¥8.09 Billion | ▼ -54.1% |
| 2020 | 0.55x | CN¥1.65 Billion | CN¥2.98 Billion | ▲ +23.8% |
| 2019 | 0.45x | CN¥938.59 Million | CN¥2.10 Billion | ▲ +38.6% |
| 2018 | 0.32x | CN¥737.26 Million | CN¥2.28 Billion | ▲ +11.6% |
| 2017 | 0.29x | CN¥552.22 Million | CN¥1.91 Billion | ▲ +27.7% |
| 2016 | 0.23x | CN¥235.77 Million | CN¥1.04 Billion | ▲ +5.0% |
| 2015 | 0.22x | CN¥216.94 Million | CN¥1.01 Billion | ▲ +1096.2% |
| 2014 | 0.02x | CN¥12.13 Million | CN¥673.22 Million | — |